Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The norepinephrine transporter (NET), encoded by the SLC6A2 gene, is a multi-pass membrane protein responsible for the reuptake of norepinephrine into presynaptic nerve terminals. This process regulates norepinephrine homeostasis in both the central and peripheral nervous systems. Dysregulation or genetic variation in NET has been implicated in several conditions, including ADHD, depression, and pain disorders. NET is a target for many antidepressants and psychostimulant drugs.
Inhibits norepinephrine reuptake by binding to the NET protein and blocking the transport of norepinephrine from the synaptic cleft back into the presynaptic neuron.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Norepinephrine Transporter Protein 1 (NET).